Population Pharmacokinetic and Pharmacodynamic Modeling of High-Dose Intermittent Ticarcillin-Clavulanate Administration in Pediatric Cystic Fibrosis Patients-Reference-Cited by-同舟云学术

Population Pharmacokinetic and Pharmacodynamic Modeling of High-Dose Intermittent Ticarcillin-Clavulanate Administration in Pediatric Cystic Fibrosis Patients

Published:2011-11 Issue:11 Volume:33 Page:1844-1850
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Zobell Jeffery T.,Stockmann Chris,Young David C.,Cash Jared,McDowell Brittany J.,Korgenski Kent,Sherwin Catherine M.T.,Spigarelli Michael,Chatfield Barbara A.,Ampofo Krow

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference22 articles.

1. Timentin [package insert],2010

2. Clinical Practice Guidelines for Pulmonary Therapies Committee;Flume;Am J Resp Crit Care Med,2009

3. High dose intermittent ticarcillin-clavulanate administration in pediatric cystic fibrosis patients;Zobell;J Cyst Fibros,2010

4. Arnoff SC, Beall RJ, Burns JL et al. Microbiology and infectious disease in cystic fibrosis. Cystic Fibrosis Foundation Consensus Conference, May 17–18, 1994, Bethesda, MD; Volume V, Section I.

5. Nelson Textbook of Pediatrics;Kliegman,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature;Clinical Pharmacokinetics;2021-11-30

2. Pharmacokinetic and Pharmacodynamic Optimization of Antibiotic Therapy in Cystic Fibrosis Patients: Current Evidences, Gaps in Knowledge and Future Directions;Clinical Pharmacokinetics;2021-01-24

3. Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model;Current Drug Metabolism;2020-01-23

4. Pharmacokinetics-pharmacodynamics of β-lactamase inhibitors: are we missing the target?;Expert Review of Anti-infective Therapy;2019-07-30

5. Pharmacokinetics of ticarcillin–clavulanate in premature infants;British Journal of Clinical Pharmacology;2019-03-06